LH
TEVA icon

Lebenthal Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Lebenthal Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,772
Closed -$255K – 391
2016
Q1 		$255K Buy
4,772
+322
+7% +$18.9K 0.04% 303
2015
Q4 		$292K Sell
4,450
-527
-11% -$32.6K 0.07% 249
2015
Q3 		$281K Sell
4,977
-467
-9% -$30.3K 0.06% 264
2015
Q2 		$336K Buy
+5,444
New +$336K 0.07% 248
2015
Q1 		– Sell
-12,966
Closed -$746K – 330
2014
Q4 		$746K Buy
+12,966
New +$722K 0.33% 88

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lebenthal Holdings's TEVA Position: Q2 2016 in Review

Lebenthal Holdings sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 4,772 shares — an estimated $255K sold.

Lebenthal Holdings first reported a position in TEVA in Q4 2014 and held it in 5 quarters. The position peaked at $746K in Q4 2014. 812 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Lebenthal Holdings reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Lebenthal Holdings sold 4,772 Teva Pharmaceuticals shares in Q2 2016, an estimated $255K.
  • Lebenthal Holdings first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Lebenthal Holdings's Teva Pharmaceuticals position peaked at $746K in Q4 2014.
  • 812 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.